Syncom Formulations Quarterly Results for Trading Insights

SYNCOMF • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹17 Cr
QSept 2025
Quarterly Results

Syncom Formulations Quarterly Results Key Highlights

  • Revenue of ₹127 Cr in Sept 2025 (-18.6% vs Mar 2025, +18.7% vs Sept 2024)
  • Net Profit of ₹17 Cr in Sept 2025 (-5.6% vs Mar 2025, +54.5% vs Sept 2024)
  • EBITDA of ₹24 Cr in Sept 2025 (-4.0% vs Mar 2025)
  • Operating Margin of 15.0% in Sept 2025 (+3.0pp vs Mar 2025)
  • Earnings Per Share of ₹0.18 in Sept 2025 (+12.5% vs Mar 2025)

Syncom Formulations Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 127 156 123 121 107 -18.6% 18.7%
Net Profit (₹ Cr) 17 18 16 19 11 - -
EBITDA (₹ Cr) 24 25 22 27 16 - -
EPS (₹) 0.18 0.16 0.21 0.23 0.16 - -
Operating Margin (%) 15.0% 12.0% 14.0% 18.0% 12.0% - -

Syncom Formulations Share Price Trend Around Quarterly Results

Visualize Syncom Formulations's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Syncom Formulations

Additional stock information and data for SYNCOMF

SYNCOMF company profile
SYNCOMF P/E ratio
SYNCOMF price range

Profitability Ratios

Profit Margin 13.4%
EBITDA Margin 18.9%
Operating Margin 15.0%
ROE (Annual) 19.9%

Balance Sheet Highlights

Total Assets ₹413 Cr
Total Equity ₹342 Cr
Current Assets ₹270 Cr
Current Liabilities ₹12 Cr

Cash Flow Analysis

Operating Cash Flow ₹23 Cr
Investing Cash Flow ₹-18 Cr
Financing Cash Flow ₹-68 Cr
Net Cash Flow ₹-63 Cr

Current Market Data

Current Price ₹12.25
Exchange NSE
Last Updated Apr 07, 2026

Revenue Trend (₹ Cr)

Dec 2025 121
Jun 2025 123
Mar 2025 156
Sept 2025 127

Net Profit Trend (₹ Cr)

Dec 2025 19
Jun 2025 16
Mar 2025 18
Sept 2025 17

Operating Margin Trend (%)

Dec 2025 18.0%
Jun 2025 14.0%
Mar 2025 12.0%
Sept 2025 15.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Syncom Formulations quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1718.0 14,875 3,125 +10.8% - 21.0% 132.2
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5850.0 2,860 689 +7.1% - 24.1% 225.3
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4051.3 3,219 591 +11.3% - 18.4% 231.0
Lupin
Sept 2025 		₹102,578.78 Cr 2298.3 6,921 1,485 +23.2% - 21.5% 71.0
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1196.1 9,135 1,337 +1.1% - 14.6% 73.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores